| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1074-7613(02)00279-0 |
| P698 | PubMed publication ID | 11869680 |
| P2093 | author name string | Richard A Flavell | |
| Yongwon Choi | |||
| E Allison Green | |||
| P2860 | cites work | CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. | Q52165458 |
| A CD8+ T-lymphocyte-mediated and CD4+ T-lymphocyte-independent autoimmune diabetes of early onset in transgenic mice | Q71682317 | ||
| Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development | Q73311881 | ||
| The temporal importance of TNFalpha expression in the development of diabetes | Q73867591 | ||
| Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens | Q77658430 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential | Q24680634 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes | Q33721729 | ||
| An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation | Q33876035 | ||
| Regulatory T cells in autoimmmunity*. | Q33904108 | ||
| Evidence for a new Graves disease susceptibility locus at chromosome 18q21. | Q34390493 | ||
| The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. | Q34452348 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions | Q36366592 | ||
| TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation | Q36368029 | ||
| Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells. | Q36375728 | ||
| TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor | Q36380989 | ||
| Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology | Q36400410 | ||
| Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens | Q36400803 | ||
| Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction | Q36401408 | ||
| The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). | Q36401438 | ||
| Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | Q40910998 | ||
| Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. | Q41700461 | ||
| Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state | Q42466421 | ||
| Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response | Q43986613 | ||
| Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice | Q45854348 | ||
| Transmission of haplotypes of microsatellite markers rather than single marker alleles in the mapping of a putative type 1 diabetes susceptibility gene (IDDM6) | Q47765109 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 183-191 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | |
| P478 | volume | 16 |
| Q36078042 | A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. |
| Q36576356 | AAV8-mediated gene transfer of interleukin-4 to endogenous beta-cells prevents the onset of diabetes in NOD mice |
| Q45111137 | Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice |
| Q37358583 | Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice |
| Q35578769 | Alloantigen-enhanced accumulation of CCR5+ 'effector' regulatory T cells in the gravid uterus |
| Q34046489 | Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor |
| Q29038508 | Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice |
| Q38236300 | Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review. |
| Q45983510 | Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells. |
| Q36371283 | Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo |
| Q34601484 | Antigen-specific peripheral shaping of the natural regulatory T cell population |
| Q39422353 | Antigen-specific regulatory T cells: are police CARs the answer? |
| Q37270469 | Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression |
| Q78467015 | Autoimmune endocrine disease |
| Q34768674 | Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. |
| Q34366449 | Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond |
| Q35145622 | Biology of the TRANCE axis |
| Q35318823 | CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes |
| Q36232697 | CD25+ CD4+ regulatory T-cells in cancer |
| Q83160035 | CD25+ T(reg) specifically suppress auto-Ab generation against pancreatic tissue autoantigens |
| Q34987296 | CD4(+) regulatory T cells in autoimmunity and allergy |
| Q35694441 | CD4+ CD25+ Treg: divide and rule? |
| Q34571847 | CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue |
| Q35978587 | CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes |
| Q52552727 | CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. |
| Q42025024 | CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta |
| Q37283379 | Cellular immunotherapy for ovarian cancer |
| Q36371658 | Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. |
| Q30438088 | Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node |
| Q35623006 | Control of autoimmunity by naturally arising regulatory CD4+ T cells |
| Q47929552 | Cost-effective analysis of candidate genes using htSNPs: a staged approach |
| Q37026641 | Creating immune privilege: active local suppression that benefits friends, but protects foes. |
| Q37076474 | DNA damage, apoptosis and langerhans cells--Activators of UV-induced immune tolerance |
| Q37368644 | DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes. |
| Q33932462 | De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells |
| Q35624565 | Deficiency of foxp3 regulatory T cells exacerbates autoimmune arthritis by altering the synovial proportions of CD4 T cells and dendritic cells |
| Q37045247 | Dendritic cells and T cells in the regulation of cutaneous immunity |
| Q34545263 | Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis. |
| Q34790078 | Detecting early-warning signals of type 1 diabetes and its leading biomolecular networks by dynamical network biomarkers |
| Q36399149 | Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells |
| Q35571875 | Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice |
| Q37441693 | Effects of RANKL-Targeted Therapy in Immunity and Cancer |
| Q57184743 | Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells |
| Q44429133 | Epinephrine promotes pulmonary angiitis: evidence for a β1-adrenoreceptor-mediated mechanism |
| Q36232655 | Function of tumor necrosis factor receptor family members on regulatory T-cells |
| Q37200819 | Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms |
| Q35539009 | Genetic separation of the transplantation tolerance and autoimmune phenotypes in NOD mice |
| Q24802813 | HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells |
| Q57275367 | High TCR diversity ensures optimal function andhomeostasis of Foxp3+regulatory Tcells |
| Q36401977 | High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis |
| Q33977505 | Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. |
| Q35954674 | Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis |
| Q35216470 | Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance |
| Q36472057 | Immunodeficiencies with autoimmune consequences. |
| Q36809762 | Indoleamine 2,3-dioxygenase and tumor-induced tolerance |
| Q30441305 | Large functional repertoire of regulatory T-cell suppressible autoimmune T cells in scurfy mice |
| Q50030501 | Low CD25 on autoreactive Tregs impairs tolerance via low dose IL-2 and antigen delivery. |
| Q38423068 | Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer |
| Q38691482 | Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation |
| Q42210265 | Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo |
| Q36790264 | Molecular Mechanisms of UV-Induced Apoptosis and Its Effects on Skin Residential Cells: The Implication in UV-Based Phototherapy |
| Q38051182 | Mucosal immunology and probiotics |
| Q35839611 | Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance. |
| Q24551158 | Natural selection of tumor variants in the generation of "tumor escape" phenotypes |
| Q38052462 | New developments in osteoimmunology |
| Q90197782 | Next-generation regulatory T cell therapy |
| Q36938431 | Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis |
| Q88248494 | Osteoimmunology |
| Q37626412 | Osteoimmunology and the effects of the immune system on bone |
| Q24655113 | Osteoimmunology: interactions of the bone and immune system |
| Q28294477 | Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems |
| Q34512471 | Polyclonal adaptive regulatory CD4 cells that can reverse type I diabetes become oligoclonal long-term protective memory cells |
| Q47106594 | RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target? |
| Q35053943 | RANK-Fc: a therapeutic antagonist for RANK-L in myeloma |
| Q24796969 | Regulating the immune system: the induction of regulatory T cells in the periphery |
| Q35129539 | Regulatory T Cells in the Control of Transplantation Tolerance and Autoimmunity |
| Q35852343 | Regulatory T cells and mechanisms of immune system control |
| Q36969926 | Regulatory T cells and toll-like receptors: regulating the regulators |
| Q34547120 | Regulatory T cells in experimental autoimmune disease |
| Q36038429 | Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer |
| Q37691776 | Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role? |
| Q35872027 | Regulatory T cells protect from autoimmune arthritis during pregnancy |
| Q36421407 | Regulatory T-cell compartmentalization and trafficking |
| Q30437086 | Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation |
| Q45877596 | Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta? |
| Q41592357 | Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome |
| Q24816917 | Role of regulatory T cells in experimental arthritis and implications for clinical use. |
| Q88639474 | Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome |
| Q36403481 | Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes |
| Q35995947 | Somatostatin receptors and autoimmune-mediated diabetes |
| Q28474036 | Specific immunosuppression with inducible Foxp3-transduced polyclonal T cells |
| Q38202989 | T-cell selection and intestinal homeostasis |
| Q41333491 | TCR sequences and tissue distribution discriminate the subsets of naïve and activated/memory Treg cells in mice |
| Q33338215 | TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression |
| Q44429966 | TNF‐α impairs peripheral tolerance towards β‐cells, and local costimulation by B7.1 enhances the effector function of diabetogenic T cells |
| Q26825668 | The CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetes |
| Q88954027 | The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells |
| Q36290302 | The many sounds of T lymphocyte silence. |
| Q24803832 | The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells |
| Q46161195 | The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice |
| Q35987374 | Tolerance, suppression and the fetal allograft |
| Q99726047 | Treg Enhancing Therapies to Treat Autoimmune Diseases |
| Q34155881 | Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice |
| Q37014824 | Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood |
| Q28506933 | Where CD4+CD25+ T reg cells impinge on autoimmune diabetes |
Search more.